NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.380
-0.070 (-4.83%)
At close: Sep 25, 2026, 4:00 PM EDT
1.420
+0.040 (2.90%)
After-hours: Sep 25, 2026, 7:38 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $160.08 million as of September 25, 2026. Its market cap has decreased by -60.99% in one year.
Market Cap
160.08M
Enterprise Value
-26.31M
1-Year Change
-60.99%
Ranking
Category
Stock Price
$1.38
ChartMarket Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $160.08M, an increase of 15.96%. That is a compound annual growth rate of 2.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 160.08M | -65.11% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 189.94M |
| PepGen | 188.39M |
| Satellos Bioscience | 183.18M |
| AN2 Therapeutics | 182.27M |
| Canton Strategic Holdings | 178.49M |
| Voyager Therapeutics | 176.84M |
| MediWound | 176.23M |
| Tonix Pharmaceuticals Holding | 175.63M |